Error creating thumbnail: convert: unable to open image `/home/wikinvest/src_live_2/mediawiki/images/9/98/New_stock.png': No such file or directory @ blob.c/OpenBlob/2480. convert: unable to open file `/home/wikinvest/src_live_2/mediawiki/images/9/98/New_stock.png' @ png.c/ReadPNGImage/2889. convert: missing an image filename `/home/wikinvest/src_live_2/mediawiki/images/thumb/9/98/New_stock.png/35px-New_stock.png' @ convert.c/ConvertImageCommand/2800.
|The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.|
Having followed these guys since the discovery in the U of Edmonton I have seen every dirty trick pulled on the stock. Today's SADIF contradicts Paladin's decision to enter and agreement with ISA. So you're sad if you believed the report. The stock rose 40% today! The FDA tactic was transparent just like today's news. Aug 20, 2010. A review of the dirty tricks should be illuminating for the potential investor. I have seen what the product does. It actually works. So I'm not surprized that polysporin et.al. would do anything to keep it off the shelves. I suspect bribery or the old boys club at work.
The problem with these tactics is that they create a stronger opponent. The FDA sends them back for another study? Again? Really :( Then an attack on the reputation to affect EU investors! Good grief people. If you have something good on the product let's see it otherwise stand out of the way. Clearly, the public isn't about to let you bankrupt the company.
Where is the stock headed... I predict about $4-$7 in the next year barring stall tactics by the EU. See, eye treatment isn't the only thing on the table and that has other companies worried. Wait till they try to bring the product in for the transplant industry.